BIIB104

DRUG4 trials

Sponsors

Biogen

Conditions

Cognitive Impairment Associated With SchizophreniaHealthy VolunteerHealthy Volunteers

Phase 1

A Study to Explore Pharmacodynamic Effects of BIIB104 on Brain Circuitry in Healthy Participants

CompletedNCT04068532

BiogenHealthy Volunteers

Start: 2019-11-15End: 2020-11-11Updated: 2021-03-22

Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

CompletedNCT04079101

BiogenHealthy Volunteers

Start: 2019-10-02End: 2019-12-27Updated: 2021-03-24

A Study to Evaluate Safety and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

CompletedNCT05148481

BiogenHealthy Volunteer

Start: 2021-11-23End: 2022-02-12Updated: 2023-04-18

Phase 2

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

CompletedNCT03745820

BiogenCognitive Impairment Associated With Schizophrenia

Start: 2018-11-15End: 2022-04-07Updated: 2023-04-18